Centre National de la Recherche Scientifique (CNRS);National University Corporation Nagoya University;INSERM - Institut National de la Santé et de la Recherche Médicale;Université Lille 1 - Sciences E
发明人:
GUERARDEL, Yann,KITAJIMA, Ken,SAWADA, Hitochi,MEGRAUD, Francis,FERRAND, Jonathan
申请号：
ES13742460
公开号：
ES2598249T3
申请日:
2013.07.30
申请国别(地区):
ES
年份:
2017
代理人:
摘要：
Pharmaceutical composition comprising, as active substance, at least two glycans or glycopeptides that independently comprise each other at least one motif of structure I: ** Formula ** in which: m1,1 and m2,1 are equal whole numbers at 0 or 1, Hex1 and Hex2 represent Glc or Gal, with the proviso that: - at least one of m1.1 and m2.1 is equal to 1, and - when Hex1 is Glc, Hex2 is Gal, - and when Hex1 is Gal, Hex2 is Glc, in association with a pharmaceutically acceptable carrier, in particular a pharmaceutical composition comprising at least two glycans or glycopeptides comprising at least one motif of structure I-1: in which m1.1 and m2.1 have the meaning indicated above, or in particular a pharmaceutical composition comprising at least two glycans or glycopeptides comprising at least one motif of structure I-2: ** Formula ** in which m1,1 and m2.1 present the meaning indicated above, or in particular A pharmaceutical composition comprising at least two glycans or glycopeptides comprising at least one motif of structure I, in which m1.1 is equal to 1 and m2.1 is equal to 0, of particular formula II: ** Formula ** or in particular a pharmaceutical composition comprising at least two glycans or glycopeptides comprising at least one motif of structure I, in which m1.1 is equal to 0 and m2.1 is equal to 1, of formula Particular III: ** Formula ** or in particular a pharmaceutical composition comprising at least two glycans or glycopeptides comprising at least one motif of structure I, in which m1.1 is equal to 0 and m2.1 is equal to 1, of particular formula III-2: ** Formula ** or in particular a pharmaceutical composition comprising at least two glycans or glycopeptides comprising at least one motif of structure I, in which m1.1 and m2, 1 are equal to 1, of particular formula 15: ** Formula ** or in particular a composition pharmaceutical composition comprising at least two glycans or glycopeptides comprising at least one motif of structure I, in which m1.1 and m2.1 ar
